Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data from Sweden

NEXT STORY
Tarsier Pharma’s Positive End-of-Phase 2 Meeting with the U.S. FDA Sets Stage for TRS01 Phase III Program in Uveitis
PREV STORY
Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

2016 Results: Significant Milestones, First Profit, More Growth to Come

Two global license and license option agreements signed with Janssen Biotech in July and ...

author_avatar
NASDAQ Market News

Generex signs Worldwide Licensing Deal with China Partners on the Development of an Ii-Key-H1 Swine Influenza Vaccine

author_avatar
NASDAQ Market News

Equillium to Present Data at the 2020 American College of Rheumatology Meeting Demonstrating CD6 Modulation Improves Kidney and Skin Pathology in Preclinical Models of Systemic Lupus Erythematosus

author_avatar
NASDAQ Market News